Two consecutive episodes of acute hepatitis C with different genotypes in a hemodialysis patient responsive to PEG-interferon monotherapy

Clinical Nephrology

Volumn 69, Issue 4, 2008, Pages 313-316

  Lederer, Stephan ^a   Zachoval, R ^a   Hasholzner, U ^b   Schiffl, H ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Medizinisches Versorgungszentrum im Sonnenblock   (Germany)

Author keywords

Genotype; Hepatitis C; PEG interferon monotherapy

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HEPATITIS B ANTIBODY; HEPATITIS B VACCINE; HEPATITIS C ANTIBODY; IMMUNOGLOBULIN G; PEGINTERFERON ALPHA2A; VIRUS RNA;

ACUTE HEPATITIS; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; DRUG TOLERABILITY; FLU LIKE SYNDROME; GENOTYPE; HEMODIALYSIS; HEPATITIS B; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; KIDNEY FAILURE; LIVER BIOPSY; LONG TERM CARE; MALE; MONOTHERAPY; PERSISTENT INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 42049091004     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP69313     Document Type: Article

References (13)

1. 2a in hepatitis C virus-positive Hemodialysis patients: results from a large, multicenter audit. J Nephrol. 2006; 19: 794-801.
2. Djordjevic V, Stojanovic K, Stojanovic M et al. Prevention of nosocomial transmission of hepatitis C infection in a hemodialysis unit. A prospective study. Int J Artif Organs. 2000; 23: 181-188.
3. EASL International Consensus Conference on Hepatitis C. Consensus statement. J Hepatol. 1999; 31 (Suppl): 3-8.
4. Espinosa M, Martin-Malo A, Alvarez de Lara MA et al. Natural history of acute HCV infection in hemodialysis patients. Clin Nephrol. 2002; 58: 143-150.
5. Gerlach JT, Diepolder HM, Zachoval R et al. Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance. Gastroenterology. 2003; 125: 80-88.
6. Ghafur A, Raza M, Labett W et al. Travel-associated acquisition of hepatitis C virus infection in patients receiving hemodialysis. Nephrol Dial Transplant. 2007; Epub ahead of print: 1-5.
7. Girndt M, Koehler H. Viral hepatitis in dialysis patients. In: Hörl WH (ed). Replacement of renal function by dialysis. Dordrecht, The Netherlands: Klüwer Academic Puplishers; 2004. p. 1379-1407.
8. 2b. N Engl J Med. 2001; 345: 1452-1457.
9. Martin P, Fabrizi F. Treatment of chronic hepatitis C infection in patients with renal failure. Clin Gastroenterol Hepatol. 2005; 3: 113-117.
10. Preston FE, Jarvis LM, Makris M et al. Heterogeneity of hepatitis C virus genotypes in hemophilia: relationship with chronic liver disease. Blood. 1995; 85: 1259-1262.
11. 2a (40 kDa) plus ribavirin in hemodialysed patients awaiting renal transplant. J Hepatol. 2007; 46: 768-774.
12. Rocha CM, Perez RM, Narciso JL et al. Interferon-α therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance. Eur J Gastroenterol Hepatol. 2007; 19: 119-123.
13. 2a treatment for chronic hepatitis C in patients on chronic hemodialysis. World J Gastroenterol. 2006; 12: 4191-4194.